Alpha Cognition Inc. ( ACOG) Discusses Commercial Adoption Metrics and Market Opportunity in Long-Term Care December 2, 2025 12:00 PM EST ...
Alpha Cognition Inc. ("Alpha Cognition" or the "Company"), a commercial-stage biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced that Alpha ...
The Alzheimer’s drugs market is projected to grow at a compound annual growth rate (CAGR) of approximately 20% during the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback